CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Open-market sale CEO sold 29,539 shares at $65.00 ($1,920,035)
- 4 Open-market sale CEO sold 90,776 shares at an average $60.18 ($5,463,230)
- 4 Open-market sale Director sold 7,893 shares at an average $60.02 ($473,709)
- 4 Open-market sale Chairman sold 36,318 shares at an average $55.98 ($2,033,109)
- 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,286 shares (to pay taxes)
- 4 Open-market sale Chairman sold 15,000 shares at an average $54.50 ($817,552)
- 4 Open-market sale Chairman sold 15,000 shares at $53.61 ($804,150)
- 4 Open-market sale Director sold 5,000 shares at $52.89 ($264,448)
- 4 Open-market sale Chief Executive Officer sold 15,785 shares at $52.11 ($822,615)
- 4 Open-market sale Director sold 8,375 shares at $52.16 ($436,876)
- 4 Open-market sale Director sold 7,342 shares at $53.00 ($389,126)
- 4 Open-market sale Director sold 376 shares at $52.81 ($19,857)
- 4 Open-market sale Director sold 1,377 shares at $51.15 ($70,434)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
- 4 Grant or award Director acquired 4,895 shares (grant or award)
Page 19 of 49 · 970 filings